Strauss Richard, Neureiter Daniel, Westenburger Bert, Wehler Markus, Kirchner Thomas, Hahn Eckhart G
Department of Medicine I, Friedrich Alexander University, Erlangen-Nuremberg, Germany.
Crit Care Med. 2004 Jun;32(6):1316-21. doi: 10.1097/01.ccm.0000127779.24232.15.
Systematic studies of the prevalence and risk factors of histiocytic hyperplasia with hemophagocytosis (HHH) in critically ill patients are lacking. The aim of our study was a) to determine the frequency and intensity of HHH in the bone marrow of patients who died on the medical intensive care unit; b) to analyze morphologic bone marrow changes; and c) to identify possible risk factors and their interactions in the pathogenesis of HHH.
A retrospective observational analysis of clinical data and autopsy findings including histologic and immunohistological analysis of bone marrow to characterize cellularity, siderosis, hemophagocytosis, and T-cell infiltrates.
The medical intensive care unit of a university hospital.
Patients were 107 consecutive patients who died and underwent autopsy.
None.
HHH was identified in 69 of the 107 patients (64.5%). Moderate to severe HHH was present in 35 of the 107 bone marrows. Univariate risk factor analysis showed that HHH was associated with various intrinsic and extrinsic factors. However, multivariate analysis identified the intensity of therapeutic interventions--represented by the Therapeutic Intervention Scoring System--as the only positive, and cardiovascular disease as the only significant negative, predictor of HHH (p <.05). Routine laboratory tests were of no value in predicting the presence of HHH. The intensity of HHH correlated significantly with siderosis and T-cell infiltrates (p <.05) but not with bone marrow cellularity.
HHH is common in medical intensive care unit nonsurvivors. Treatment intensity and a noncardiovascular cause of death are predictors of HHH. Sepsis and blood transfusion may have a synergistic effect on the triggering of HHH. HHH in bone marrow is associated with enhanced T-cell infiltrates, suggesting that T cells may play an important role in its mediation.
目前缺乏对危重症患者噬血细胞性组织细胞增生症(HHH)患病率及危险因素的系统研究。我们研究的目的是:a)确定在医学重症监护病房死亡患者骨髓中HHH的频率和强度;b)分析骨髓形态学变化;c)识别HHH发病机制中可能的危险因素及其相互作用。
对临床数据和尸检结果进行回顾性观察分析,包括对骨髓进行组织学和免疫组织学分析,以确定细胞成分、含铁血黄素沉着、噬血细胞现象和T细胞浸润情况。
一所大学医院的医学重症监护病房。
107例连续死亡并接受尸检的患者。
无。
107例患者中有6例(64.5%)被诊断为HHH。107份骨髓样本中有35份存在中度至重度HHH。单因素危险因素分析显示,HHH与多种内在和外在因素有关。然而,多因素分析确定,以治疗干预评分系统表示的治疗干预强度是HHH唯一的阳性预测因素,而心血管疾病是唯一显著的阴性预测因素(p<0.05)。常规实验室检查对预测HHH的存在没有价值。HHH的强度与含铁血黄素沉着和T细胞浸润显著相关(p<0.05),但与骨髓细胞成分无关。
HHH在医学重症监护病房的非存活患者中很常见。治疗强度和非心血管疾病死因是HHH的预测因素。脓毒症和输血可能对HHH的触发有协同作用。骨髓中的HHH与T细胞浸润增加有关,提示T细胞可能在其介导过程中起重要作用。